Zoledronic Acid
Composition
The formulation contains Zoledronic Acid 4 mg/5 ml with mannitol, sodium citrate, and water for injection as the active ingredient.
Indications
Indicated for the treatment of hypercalcemia of malignancy, multiple myeloma, and bone metastases from solid tumors; also used for osteoporosis.
Side effects
Common side effects include fever, fatigue, bone pain, nausea, vomiting, anemia, constipation, and diarrhea.
Precautions
Monitor renal function, hydration
Contraindications
Hypocalcemia, severe renal impairment
Dosage and administration
4 mg infused over no less than 15 minutes, frequency depends on condition
Countries
USA, Canada, EU
Available Forms
Injection vial